Get Online Consultation Dr. Kausik Bhattacharya Radiation Oncologist With Email Id, Apollo Hospitals, Jubilee Hills, Hyderabad India

Dr. Kausik Bhattacharya

MBBS, MD – Radiation Oncology
Consultant – Radiation Oncology

Radiation Oncologist- 21 Years of Experience

Doctor Profile

Dr. Kausik Bhattacharya is a Radiation Oncologist at Apollo Hospitals in Jubilee Hills, Hyderabad and has an experience of 17 years in this field. Dr. Kausik completed MBBS from Sriram Chandra Bhanj Medical College, Cuttack in 1994 and MD – Radiotherapy from AH Regional Cancer Centre in 1999. He specializes in Head and Neck Cancer, Organ Preservation, Rehabilitation of Cancer Patients, Brain Tumor Management, Stereotactic Radiotherapy and Radiosurgery. He is a member of Association of Radiation Oncologists of India (AROI). Dr. Bhattacharya was previously appointed as Senior Registrar in TATA Memorial Hospital, Mumbai, Safdarjung Hospital, New Delhi, Faculty in Regional Cancer Center – Cuttack and Consultant Radiation Oncologist – Yashoda Cancer Institute Hyderabad.

 

Education

  • MBBS – SCB Medical College, Cuttack, Orissa, 1994
  • MD – Radiation Oncology – AH Regional Cancer Centre, Cuttack, 1999

 

Memberships

  • Life Member – Association of Radiation Oncologists of India

 

Experience

  • Radiation Oncology, Consultant- Apollo Health City, Jubilee Hills, Hyderabad , currently working
  • Radiation Oncology, Consultant- Apollo Emergency Centre, Kukatpally , currently working
  • Radiation Oncology, Consultant- Yashoda Hospitals, Secunderabad, AP
  • Radiation Oncology, Faculty- AH Regional Cancer Centre, Cuttack, Orissa , 2002
  • Registras Office, Senior Registrar- TATA Memorial Hospital, Mumbai , 2000
  • Radiation Oncology, Senior Resident- Safdarjung Hospital, New Delhi , 1999

 

Awards and Achievements

  • Research Assistant in Phase – II study Of Cisplatin and Gemcitabine in Recurrwnt and Metastatic Head and Neck Cancers ( Funded by Eli Lilly, France)
  • Research Assistant in International Co-ordinated research on the Chemical Modification of Cancer Treatment, using AK- 2123 (Funded by Health Research Foundation, Japan)
<< return to doctors

Leave a Reply

Scroll to Top